[1]
Aslı Haykır Solay et al. 2019. Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity. Turkish Journal of Gastroenterology. 29, 5 (Jul. 2019), 561–565.